Article Text

Download PDFPDF
Group cognitive-behavioural therapy may reduce symptoms and impairment in adolescents with attention-deficit/hyperactivity disorder
  1. David Coghill
  1. University of Dundee, Dundee, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

ABSTRACT FROM: Vidal R, Castells J, Richarte V, et al. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2015;54:275–82.

What is already known on this topic

Persistence of attention-deficit hyperactivity disorder (ADHD) into adolescence is associated with a broad range of negative outcomes1 and high rates of treatment discontinuation.2 While clinical guidelines recommend non-pharmacological therapies as the first-line treatment for adolescents with ADHD3 the evidence to support this recommendation is sparse and generally not convincing. More specifically there is inadequate evidence to properly support the efficacy of either group or individual cognitive-behavioural therapy (CBT) for this patient group.4

Methods of the study

In this randomised controlled trial, participants were 119 adolescents aged between 15 and 21 years old who met DSM-IV criteria for ADHD, recruited from two specialist ADHD services in Spain. All participants were on stabilised doses for …

View Full Text


  • Competing interests DC has research funded by Shire Pharmaceuticals and Vifor Pharma. He has received honoraria, consultancy and speaking fees from Janssen-Cilag, Eli Lilly, Medice, Novartis, Shire and Vifor Pharma, and royalties from the Oxford University Press.